Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Glaucoma, Suspect: later-stage trial registry
4 of 4 indexed Glaucoma, Suspect trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Glaucoma, Suspect: 4 US clinical trials tracked, 4 recruiting.
Glaucoma, Suspect is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Jorvec, running 1 of these trials.
Enrollment posture brief
Registry condition glaucoma-suspect
OPEN 4 | RECR 100% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Glaucoma, Suspect lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Glaucoma, Suspect on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Glaucoma, Suspect is recruiting above its size-band peers.
4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Automated Applanation Tonometry - Updated
Duke University
NCT07298356
CLAD Deconvolved PERG Responses in Glaucoma Patients
Jorvec
NCT06388096
A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics
Nova Southeastern University
NCT02157025
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
University of Miami
NCT07217678
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Glaucoma, Suspect records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Glaucoma, Suspect trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Glaucoma, Suspect page
4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Glaucoma, Suspect trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jorvec sponsors the most Glaucoma, Suspect trials on record, review their full trial history before evaluating a specific study. See Jorvec's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Glaucoma, Suspect condition card totals 4 registered trials; most-linked intervention Durysta, Bimatoprost Intracameral Implant 10 µg; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.